KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Dynavax Technologies (DVAX) over the last 15 years, with Q3 2025 value amounting to $6.7 million.

  • Dynavax Technologies' Other Accumulated Expenses rose 5093.53% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 5093.53%. This contributed to the annual value of $4.3 million for FY2024, which is 464.6% down from last year.
  • Per Dynavax Technologies' latest filing, its Other Accumulated Expenses stood at $6.7 million for Q3 2025, which was up 5093.53% from $5.5 million recorded in Q2 2025.
  • Dynavax Technologies' Other Accumulated Expenses' 5-year high stood at $6.7 million during Q3 2025, with a 5-year trough of $3.4 million in Q1 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $4.5 million (2023), whereas its average is $4.7 million.
  • As far as peak fluctuations go, Dynavax Technologies' Other Accumulated Expenses plummeted by 5553.17% in 2021, and later skyrocketed by 8948.15% in 2022.
  • Over the past 5 years, Dynavax Technologies' Other Accumulated Expenses (Quarter) stood at $4.7 million in 2021, then increased by 1.86% to $4.8 million in 2022, then decreased by 5.34% to $4.5 million in 2023, then dropped by 4.65% to $4.3 million in 2024, then soared by 55.38% to $6.7 million in 2025.
  • Its Other Accumulated Expenses was $6.7 million in Q3 2025, compared to $5.5 million in Q2 2025 and $5.7 million in Q1 2025.